Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Government Contract opportunity from Department Of Health And Human Services was posted on July 8, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Trade-In Equipment Removal and Disposal

Closed
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 562920
SLED
FY27 Inert Crushing at Transfer Station
Solicitation # 2026-NIBCONST-594
The City of Prescott is soliciting bids for the FY27 Inert Crushing project at the Transfer Station located at 2800 Sundog Ranch Road. The scope of work involves the on-site crushing and screening of two distinct stockpiles—one consisting of a concrete-inert mixture and the other of asphalt concrete, concrete, and rubble—into a 1 1/4 inch minus product. The contractor is required to document total tonnage produced using off-of-the-belt scale evidence and must coordinate operations with the Solid Waste or Street Maintenance Superintendents to avoid interfering with daily station activities. The project must be completed within 90 calendar days from the Notice to Proceed, with the contract being awarded to the lowest qualified bidder. The procurement process requires a proposal guarantee of at least 10 percent of the total bid price and the provision of performance and payment bonds. Bidders must submit a detailed bidding schedule including unit rates for crushing and fixed costs for mobilization and contract allowances. Technical compliance is governed by the City of Prescott Supplement to the MAG Uniform Standard Specifications and project-specific Special Provisions, with quality control testing performed by an independent geotechnical firm. Additionally, the project adheres to federal and state regulations, including the Buy America preference and American Iron and Steel requirements for applicable funding.
Public Works

POSTED

8 days ago

DEADLINE

in 19 days

AI Contract Overview

Show more

The contract pertains to the removal and environmentally compliant disposal of legacy cell imaging equipment to facilitate the installation of new systems. The work is classified under NAICS code 562920, indicating it falls within the waste treatment and disposal services sector, and is structured as a subcontract requiring specialized handling to ensure regulatory compliance with environmental standards. The agency issuing this requirement is the FDA Office of Acquisition and Grant Services within the Department of Health and Human Services, and the performance location is unspecified but will involve on-site operations at facilities housing the legacy equipment. The solicitation was posted on July 8, 2026, with a firm deadline for responses set for July 16, 2026, at 2:00 PM. Although no set-aside designation has been specified, the requirement demands precise logistics for the safe dismantling, transportation, and disposal of potentially hazardous electronic waste. All activities must adhere to federal and state environmental regulations to prevent contamination and ensure accountability. Contractors must demonstrate proven experience in handling biomedical imaging hardware and managing end-of-life electronics through approved, certified disposal channels.

General Info

Remove and dispose of legacy cell imaging equipment per environmental regulations for FDA.

Agency

Department Of Health And Human Services → FDA Office Of Acq Grant SvcsView Agency

NAICS

562920 - Materials Recovery FacilitiesView NAICS

Place of Performance

MD

Set-Aside

NONE

Documents

This scope was carved out of 75F40126Q135511.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

Agilent Cytation 9 Cell Imaging Multimode Reader, or equivalent instrument

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseClosed
Posted

subcontract

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → FDA Office Of Acq Grant Svcs
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Health And Human Services → FDA Office Of Acq Grant Svcs
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Removal and environmentally compliant disposal of legacy cell imaging equipment during new system installation.

More opportunities from Department Of Health And Human Services → FDA Office Of Acq Grant Svcs

Same awarding agency

NAICS: 541714
New
Federal
Human Hindbrain Organoid Functional Assay Services.
Solicitation # RFQ_CDR-2026-135968
The U.S. Food and Drug Administration, through the Center for Drug Evaluation and Research, intends to award a sole-source, firm-fixed-price purchase order to OrganoTherapeutics SARL for human iPSC-derived hindbrain organoid functional assay services. This acquisition, conducted under FAR Part 12 as a commercial service, aims to support in vitro research on drug-induced effects on respiratory-relevant neural circuits. The scope of work includes the provision of human hindbrain organoids and associated culture materials, with twelve scheduled deliveries to the FDA White Oak Campus in Silver Spring, Maryland. The first delivery will consist of 96 organoids, followed by eleven subsequent deliveries of 48 organoids each. The contractor will perform functional characterization at its own laboratory using three-dimensional multi-electrode array technology to assess electrophysiological responses to FDA-identified drug and reversal-agent combinations. Key deliverables include the raw and analyzed data, analysis files, and comprehensive study reports. The anticipated period of performance is 18 months from the date of award. Award will be based on best value, with technical capability and past performance weighted more heavily than price. All invoicing must be processed electronically through the U.S. Department of Treasury's Invoice Processing Platform.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

about 24 hours ago

DEADLINE

in 5 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS